Old Web
English
Sign In
Acemap
>
authorDetail
>
Ivy Li
Ivy Li
Regeneron
Medicine
Placebo
Alirocumab
PCSK9
Internal medicine
5
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The impact of Super Visa on Chinese immigrant families' settlement in Canada
2021
Ivy Li
Show All
Source
Cite
Save
Citations (0)
Ivy Li Photograph
2020
Ivy Li
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
2018
The Korean Journal of Internal Medicine
Chang-Wook Nam
Dong Soo Kim
Jianyong Li
Marie T. Baccara-Dinet
Ivy Li
Ji-Hyun Kim
Chong-Jin Kim
Show All
Source
Cite
Save
Citations (4)
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALIROCUMAB IN HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA NOT ADEQUATELY CONTROLLED WITH THEIR LIPID-MODIFYING THERAPY IN SOUTH KOREA AND TAIWAN
2017
Journal of the American College of Cardiology
Kwang K. Koh
Chang-Wook Nam
Ting-Hsing Chao
Ming-En Liu
Chiung-Jen Wu
Dong-Soo Kim
Chong-Jin Kim
Ivy Li
Jianyong Li
Marie T. Baccara-Dinet
Pi-Jung Hsiao
Chern-En Chiang
Show All
Source
Cite
Save
Citations (1)
A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT)
2017
Journal of Clinical Lipidology
Kwang Kon Koh
Chang-Wook Nam
Ting-Hsing Chao
Ming En Liu
Chiung Jen Wu
Dong Soo Kim
Chong-Jin Kim
Ivy Li
Jianyong Li
Marie T. Baccara-Dinet
Pi-Jung Hsiao
Chern En Chiang
Show All
Source
Cite
Save
Citations (26)
1